Docoh
Loading...

28 results

Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
EX-1.1
PCSA Processa Pharmaceuticals Inc
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
authorities applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
directed to making, having made, producing, Manufacturing, processing, filling, finishing, packaging, labeling, quality assurance testing and release
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
of the final biological product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate … meet applicable child-resistant packaging requirements under the U.S. Poison Prevention Packaging Act. Manufacturing, sales, promotion and other
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii
8-K
EX-1.1
PCSA Processa Pharmaceuticals Inc
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
that regulates the design, development, testing, manufacturing, processing, storing, importing or exporting, licensing, labeling or packaging
424B4
erxagjfe17c
5 Oct 20
Prospectus supplement with pricing info
4:16pm
S-1/A
00ob 8now
30 Sep 20
IPO registration (amended)
4:06pm
S-1/A
ti9zl6
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-1.1
d1ex0jwfn fa
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-10.13
qprnqksq7 vdgyskn
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-10.11
g520fq9e3s13kbc0niz5
16 Sep 20
IPO registration (amended)
8:00pm
8-K
EX-10.1
k2juv2obvnoohxvgurf
27 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
drvmcvlxogp2z
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
S-1/A
jy8pa4xd5b9 1h
17 Jul 20
IPO registration (amended)
5:25pm
10-K
0xlxjfb
5 Mar 20
Annual report
7:00pm
S-1
lfwyrh bz
13 Dec 19
IPO registration
5:32pm
10-K/A
6ft8lkgeww6gai 9e
5 Apr 19
Annual report (amended)
9:40pm
10-K
jilsy0pf lf
28 Mar 19
Annual report
5:25pm
424B3
rgdv v58lfj9k
9 Nov 18
Prospectus supplement
5:04pm
S-1/A
w2rwx3ld7b1lltfnen
30 Oct 18
IPO registration (amended)
4:19pm